Effects of TNF-α and curcumin on the expression of thrombomodulin and endothelial protein C receptor in human endothelial cells

Thrombosis Research

Volumn 115, Issue 5, 2005, Pages 417-426

  Nan, Bicheng ^a   Lin, Peter ^a   Lumsden, Alan B ^a   Yao, Qizhi ^a   Chen, Changyi ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Antioxidant; Curcumin; Endothelial cell; Endothelial protein C receptor; Inflammation; Thrombomodulin; TNF

Indexed keywords

CURCUMIN; MESSENGER RNA; PROTEIN C RECEPTOR; RECEPTOR; THROMBOMODULIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ARTICLE; CELL CULTURE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORONARY ARTERY; DRUG EFFECT; ENDOTHELIUM CELL; FOOD COLOR; HUMAN; HUMAN CELL; LUNG; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; REAL TIME POLYMERASE CHAIN REACTION; RECEPTOR DOWN REGULATION; SKIN; SPICE; UMBILICAL VEIN; WESTERN BLOTTING;

EID: 14144250943     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.thromres.2004.10.010     Document Type: Article

References (41)

1. J. Vilcek, and T.H. Lee Tumor necrosis factor. New insights into the molecular mechanisms of its multiple actions J. Biol. Chem. 266 1991 7313 7316
2. M.P. Bevilacqua, J.S. Pober, G.R. Majeau, W. Fiers, R.S. Cotran, and M.A. Gimbrone Jr. Recombinant tumor necrosis factor induces procoagulant activity in cultured human vascular endothelium: characterization and comparison with the actions of interleukin 1 Proc. Natl. Acad. Sci. U. S. A. 83 1986 4533 4537
3. P.P. Nawroth, and D.M. Stern Modulation of endothelial cell hemostatic properties by tumor necrosis factor J. Exp. Med. 163 1986 740 745
4. R.R. Schleef, M.P. Bevilacqua, M. Sawdey, M.A. Gimbrone Jr, and D.J. Loskutoff Cytokine activation of vascular endothelium. Effects on tissue-type plasminogen activator and type 1 plasminogen activator inhibitor J. Biol. Chem. 263 1988 5797 5803
5. M.P. Bevilacqua, S. Stengelin, M.A. Gimbrone Jr, and B. Seed Endothelial leukocyte adhesion molecule 1: an inducible receptor for neutrophils related to complement regulatory proteins and lectins Science 243 1989 1160 1165
6. Y. Yoshii, Y. Okada, S. Sasaki, H. Mori, K. Oida, and H. Ishii Expression of thrombomodulin in human aortic smooth muscle cells with special reference to atherosclerotic lesion types and age differences Med. Electron Microsc. 36 2003 165 172
7. M.J. Wood, L.A. Becvar, J.H. Prieto, G. Melacini, and E.A. Komives NMR structures reveal how oxidation inactivates thrombomodulin Biochemistry 42 2003 11932 11942
8. J. Dorffler-Melly, M. de Kruif, L.A. Schwarte, R.F. Franco, S. Florquin, and C.A. Spek Functional thrombomodulin deficiency causes enhanced thrombus growth in a murine model of carotid artery thrombosis Basic Res. Cardiol. 98 2003 347 352
9. T. Myles, T. Nishimura, T.H. Yun, M. Nagashima, J. Morser, and A.J. Patterson Thrombin activatable fibrinolysis inhibitor, a potential regulator of vascular inflammation J. Biol. Chem. 278 2003 51059 51067
10. C.T. Esmon The protein C pathway Chest 124 2003 26S 32S
11. C.T. Esmon New mechanisms for vascular control of inflammation mediated by natural anticoagulant proteins J. Exp. Med. 196 2002 561 567
12. K. Fukudome, and C.T. Esmon Identification, cloning, and regulation of a novel endothelial cell protein C/activated protein C receptor J. Biol. Chem. 269 1994 26486 26491
13. B.O. Villoutreix, A.M. Blom, and B. Dahlback Structural prediction and analysis of endothelial cell protein C/activated protein C receptor Protein Eng. 12 1999 833 840
14. Z. Laszik, A. Mitro, F.B. Taylor Jr, G. Ferrell, and C.T. Esmon Human protein C receptor is present primarily on endothelium of large blood vessels: implications for the control of the protein C pathway Circulation 96 1997 3633 3640
15. X. Ye, K. Fukudome, N. Tsuneyoshi, T. Satoh, O. Tokunaga, and K. Sugawara The endothelial cell protein C receptor (EPCR) functions as a primary receptor for protein C activation on endothelial cells in arteries, veins, and capillaries Biochem. Biophys. Res. Commun. 259 1999 671 677
16. K. Fukudome, X. Ye, N. Tsuneyoshi, O. Takunaga, K. Sugawara, and H. Mizokami Activation mechanism of anticoagulant protein C in large blood vessels involving the endothelial cell protein C receptor J. Exp. Med. 187 1998 1029 1035
17. F. Espana, P. Medina, S. Navarro, A. Estelles, and J. Aznar Inherited abnormalities in the protein C activation pathway Pathophysiol. Haemost. Thromb. 32 2002 241 244
18. A.K. Singh, G.S. Sidhu, T. Deepa, and R.K. Maheshwari Curcumin inhibits the proliferation and cell cycle progression of human umbilical vein endothelial cell Cancer Lett. 107 1996 109 115
19. H. Ishii, K. Takada, T. Higuchi, and J. Sugiyama Verotoxin-1 induces tissue factor expression in human umbilical vein endothelial cells through activation of NF-kappaB/Rel and AP-1 Thromb. Haemost. 84 2000 712 721
20. U.R. Pendurthi, J.T. Williams, and L.V. Rao Inhibition of tissue factor gene activation in cultured endothelial cells by curcumin. Suppression of activation of transcription factors Egr-1, AP-1, and NF-kappa B Arterioscler. Thromb. Vasc. Biol. 17 1997 3406 3413
21. A. Bierhaus, Y. Zhang, P. Quehenberger, T. Luther, M. Haase, and M. Muller The dietary pigment curcumin reduces endothelial tissue factor gene expression by inhibiting binding of AP-1 to the DNA and activation of NF-kappa B Thromb. Haemost. 77 1997 772 782
22. S.I. Yamagishi, Y. Inagaki, K. Nakamura, and T. Imaizumi Azelnidipine, a newly developed long-acting calcium antagonist, inhibits tumor necrosis factor-alpha-induced interleukin-8 expression in endothelial cells through its anti-oxidative properties J. Cardiovasc. Pharmacol. 43 2004 724 730
23. A. Kumar, S. Dhawan, N.J. Hardegen, and B.B. Aggarwal Curcumin (Diferuloylmethane) inhibition of tumor necrosis factor (TNF)-mediated adhesion of monocytes to endothelial cells by suppression of cell surface expression of adhesion molecules and of nuclear factor-kappaB activation Biochem. Pharmacol. 55 1998 775 783
24. H.C. Huang, G.Y. Shi, S.J. Jiang, C.S. Shi, C.M. Wu, and H.Y. Yang Thrombomodulin-mediated cell adhesion: involvement of its lectin-like domain J. Biol. Chem. 278 2003 46750 46759
25. E.M. Conway, and R.D. Rosenberg Tumor necrosis factor suppresses transcription of the thrombomodulin gene in endothelial cells Mol. Cell. Biol. 8 1988 5588 5592
26. S. Kapiotis, J. Besemer, D. Bevec, P. Valent, P. Bettelheim, and K. Lechner Interleukin-4 counteracts pyrogen-induced downregulation of thrombomodulin in cultured human vascular endothelial cells Blood 78 1991 410 415
27. H. Ishii, S. Horie, K. Kizaki, and M. Kazama Retinoic acid counteracts both the downregulation of thrombomodulin and the induction of tissue factor in cultured human endothelial cells exposed to tumor necrosis factor Blood 80 1992 2556 2562
28. G. Murugesan, M.R. Rani, R.M. Ransohoff, R.E. Marchant, and K. Kottke-Marchant Endothelial cell expression of monocyte chemotactic protein-1, tissue factor, and thrombomodulin on hydrophilic plasma polymers J. Biomed. Mater. Res. 49 2000 396 408
29. S.R. Lentz, M. Tsiang, and J.E. Sadler Regulation of thrombomodulin by tumor necrosis factor-alpha: comparison of transcriptional and posttranscriptional mechanisms Blood 77 1991 542 550
30. E.M. Scarpati, and J.E. Sadler Regulation of endothelial cell coagulant properties. Modulation of tissue factor, plasminogen activator inhibitors, and thrombomodulin by phorbol 12-myristate 13-acetate and tumor necrosis factor J. Biol. Chem. 264 1989 20705 20713
31. K.L. Moore, C.T. Esmon, and N.L. Esmon Tumor necrosis factor leads to the internalization and degradation of thrombomodulin from the surface of bovine aortic endothelial cells in culture Blood 73 1989 159 165
32. C.T. Esmon Crosstalk between inflammation and thrombosis Maturitas 47 2004 305 314
33. J.L. Arbiser, N. Klauber, R. Rohan, R. van Leeuwen, M.T. Huang, and C. Fisher Curcumin is an in vivo inhibitor of angiogenesis Mol. Med. 4 1998 376 383
34. D. Thaloor, A.K. Singh, G.S. Sidhu, P.V. Prasad, H.K. Kleinman, and R.K. Maheshwari Inhibition of angiogenic differentiation of human umbilical vein endothelial cells by curcumin Cell Growth Differ. 9 1998 305 312
35. S. Hanazawa, A. Takeshita, S. Amano, T. Semba, T. Nirazuka, and H. Katoh Tumor necrosis factor-alpha induces expression of monocyte chemoattractant JE via fos and jun genes in clonal osteoblastic MC3T3-E1 cells J. Biol. Chem. 268 1993 9526 9532
36. K. Kanda, G.T. Hayman, M.D. Silverman, and P.I. Lelkes Comparison of ICAM-1 and VCAM-1 expression in various human endothelial cell types and smooth muscle cells Endothelium 6 1998 33 44
37. E.W. Ades, F.J. Candal, R.A. Swerlick, V.G. George, S. Summers, and D.C. Bosse HMEC-1: establishment of an immortalized human microvascular endothelial cell line J. Invest. Dermatol. 99 1992 683 690
38. M.J. Ribeiro, D.J. Phillips, J.M. Benson, B.L. Evatt, E.W. Ades, and W.C. Hooper Hemostatic properties of the SV-40 transfected human microvascular endothelial cell line (HMEC-1). A representative in vitro model for microvascular endothelium Thromb. Res. 79 1995 153 161
39. M. Ahmad, P. Theofanidis, and R.M. Medford Role of activating protein-1 in the regulation of the vascular cell adhesion molecule-1 gene expression by tumor necrosis factor-alpha J. Biol. Chem. 273 1998 4616 4621
40. T.E. Scholzen, T. Brzoska, D.H. Kalden, M. Hartmeyer, M. Fastrich, and T.A. Luger Expression of functional melanocortin receptors and proopiomelanocortin peptides by human dermal microvascular endothelial cells Ann. N.Y. Acad. Sci. 885 1999 239 253
41. D.S. Zhong, X.H. Lu, B.S. Conklin, P.H. Lin, A.B. Lumsden, and Q. Yao HIV protease inhibitor ritonavir induces cytotoxicity of human endothelial cells Arterioscler. Thromb. Vasc. Biol. 22 2002 1560 1566